Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Bojana Andrejic Visnjic"'
Autor:
Jasna Pesic, Vladimir Vidovic, Ivana Kolarov Bjelobrk, Jasna Trifunovic, Nemanja Petrovic, Jelena Radic, Bojana Vranjkovic, Bojana Andrejic Visnjic
Publikováno v:
Journal of Chemotherapy. 34:264-271
The choice of the anti-HER2 agent depends on country-specific availability, the specific, previously administered anti-HER2 therapy and the relapse-free interval, although there is not much published data on the use of lapatinib after progression on